I. Shakhnoza and D. Qamardinovna, Trans., “Effect of SGLT-2 inhibitors on hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus and MASLD”, UOC, no. 1, May 2026, doi: 10.57033/RSSPMCE-2026-00022.